Life,
Journal Year:
2023,
Volume and Issue:
13(12), P. 2326 - 2326
Published: Dec. 11, 2023
This
study
retrospectively
analyzed
the
medical
records
of
602
patients
with
first-time
positive
results
for
HCV
nucleic
acid
test
between
1
May
2021
and
31
March
2023,
exploring
association
DAA
treatment
SARS-CoV-2
infection.
The
showed
that
9.8%
were
co-infected
SARS-CoV-2.
Gender,
age,
vaccination
status,
genotype
did
not
significantly
affect
However,
undergoing
lower
rates
infection
mortality
compared
to
those
treatment.
analysis
also
different
treatments,
Epclusa
Maviret
showing
superior
protection
against
Furthermore,
this
explored
severity
in
having
completed
It
revealed
diagnosed
COVID-19
during
experienced
only
mild
symptoms,
none
died,
suggesting
a
potential
protective
effect
severe
outcomes
findings
contribute
understanding
interplay
HCV,
treatment,
infection,
highlighting
need
continued
monitoring
healthcare
measures
individuals
chronic
conditions
ongoing
pandemic.
Journal of Gastrointestinal and Liver Diseases,
Journal Year:
2024,
Volume and Issue:
33(2), P. 278 - 280
Published: June 29, 2024
Gluten
does
not
induce
gastrointestinal
symptoms
in
healthy
volunteers:
the
British
Broadcasting
Company
ExperimentTo
Editor,
While
gluten-free
diet
(GFD)
is
best
treatment
for
clinical
gluten
sensitivity
(GS)
[(e.g.coeliac
disease
(CD),
nonceliac
(NCGS)],
scientific
opinion
supports
that
safe
general
population
[1].However,
celebrity/athletic
endorsement
of
GFD
has
cultivated
an
image
as
"unhealthy"
[2]."Lifestylers",
"free
from"
or
"people
who
avoid
gluten"
are
individuals
a
lifestyle
choice.American
market
research
[3]
found
44%
people
buy
food
reasons
other
than
GS,
and
65%
believe
generally
healthier.This
trend
driven
worldwide
industry
from
values
$1.7bn
2011
to
$3.5bn
2016,
it
forecast
reach
$4.7bn
2020
[4].The
surge
popularity
also
encouraged
opposing
belief
"fad"
[2].This
unfortunate
with
CD/NCGS
express
they
taken
seriously
restaurants,
even
face
dismissive
attitudes
non-specialist
clinicians
[5].The
drawing
clear
line
between
those
do
benefit
needed
ground
public
perspective
on
these
issues.For
this
reason,
conjunction
(BBC)
we
undertook
televised
experiment.Our
hypothesis
was
giving
volunteers
(via
gluten-containing
flour)
should
cause
any
symptoms.Participants
(who
received
no
financial
incentives),
recruited
by
BBC
advertising,
were
≥18
years,
had
diagnosed
gluten-related
disorders
followed
diets.The
experiment
aimed
recruit
30
subjects
divide
into
two
groups;
previous
data
available
but
NCGS
Double
Blind
Randomised
Controlled
Trials
(DBRCT)
have
reported
symptom
changes
induced
which
would
carry
89.2%
power
if
observed
within
group
N=15
[6].Participants
point
care
tested
(IgA/
Journal of Gastrointestinal and Liver Diseases,
Journal Year:
2024,
Volume and Issue:
33(2), P. 281 - 281
Published: June 29, 2024
Gluten
does
not
induce
gastrointestinal
symptoms
in
healthy
volunteers:
the
British
Broadcasting
Company
ExperimentTo
Editor,
While
gluten-free
diet
(GFD)
is
best
treatment
for
clinical
gluten
sensitivity
(GS)
[(e.g.coeliac
disease
(CD),
nonceliac
(NCGS)],
scientific
opinion
supports
that
safe
general
population
[1].However,
celebrity/athletic
endorsement
of
GFD
has
cultivated
an
image
as
"unhealthy"
[2]."Lifestylers",
"free
from"
or
"people
who
avoid
gluten"
are
individuals
a
lifestyle
choice.American
market
research
[3]
found
44%
people
buy
food
reasons
other
than
GS,
and
65%
believe
generally
healthier.This
trend
driven
worldwide
industry
from
values
$1.7bn
2011
to
$3.5bn
2016,
it
forecast
reach
$4.7bn
2020
[4].The
surge
popularity
also
encouraged
opposing
belief
"fad"
[2].This
unfortunate
with
CD/NCGS
express
they
taken
seriously
restaurants,
even
face
dismissive
attitudes
non-specialist
clinicians
[5].The
drawing
clear
line
between
those
do
benefit
needed
ground
public
perspective
on
these
issues.For
this
reason,
conjunction
(BBC)
we
undertook
televised
experiment.Our
hypothesis
was
giving
volunteers
(via
gluten-containing
flour)
should
cause
any
symptoms.Participants
(who
received
no
financial
incentives),
recruited
by
BBC
advertising,
were
≥18
years,
had
diagnosed
gluten-related
disorders
followed
diets.The
experiment
aimed
recruit
30
subjects
divide
into
two
groups;
previous
data
available
but
NCGS
Double
Blind
Randomised
Controlled
Trials
(DBRCT)
have
reported
symptom
changes
induced
which
would
carry
89.2%
power
if
observed
within
group
N=15
[6].Participants
point
care
tested
(IgA/
Journal of Gastrointestinal and Liver Diseases,
Journal Year:
2024,
Volume and Issue:
33(2), P. 282 - 284
Published: June 29, 2024
Gluten
does
not
induce
gastrointestinal
symptoms
in
healthy
volunteers:
the
British
Broadcasting
Company
ExperimentTo
Editor,
While
gluten-free
diet
(GFD)
is
best
treatment
for
clinical
gluten
sensitivity
(GS)
[(e.g.coeliac
disease
(CD),
nonceliac
(NCGS)],
scientific
opinion
supports
that
safe
general
population
[1].However,
celebrity/athletic
endorsement
of
GFD
has
cultivated
an
image
as
"unhealthy"
[2]."Lifestylers",
"free
from"
or
"people
who
avoid
gluten"
are
individuals
a
lifestyle
choice.American
market
research
[3]
found
44%
people
buy
food
reasons
other
than
GS,
and
65%
believe
generally
healthier.This
trend
driven
worldwide
industry
from
values
$1.7bn
2011
to
$3.5bn
2016,
it
forecast
reach
$4.7bn
2020
[4].The
surge
popularity
also
encouraged
opposing
belief
"fad"
[2].This
unfortunate
with
CD/NCGS
express
they
taken
seriously
restaurants,
even
face
dismissive
attitudes
non-specialist
clinicians
[5].The
drawing
clear
line
between
those
do
benefit
needed
ground
public
perspective
on
these
issues.For
this
reason,
conjunction
(BBC)
we
undertook
televised
experiment.Our
hypothesis
was
giving
volunteers
(via
gluten-containing
flour)
should
cause
any
symptoms.Participants
(who
received
no
financial
incentives),
recruited
by
BBC
advertising,
were
≥18
years,
had
diagnosed
gluten-related
disorders
followed
diets.The
experiment
aimed
recruit
30
subjects
divide
into
two
groups;
previous
data
available
but
NCGS
Double
Blind
Randomised
Controlled
Trials
(DBRCT)
have
reported
symptom
changes
induced
which
would
carry
89.2%
power
if
observed
within
group
N=15
[6].Participants
point
care
tested
(IgA/
Journal of Gastrointestinal and Liver Diseases,
Journal Year:
2024,
Volume and Issue:
33(2), P. 280 - 281
Published: June 29, 2024
Gluten
does
not
induce
gastrointestinal
symptoms
in
healthy
volunteers:
the
British
Broadcasting
Company
ExperimentTo
Editor,
While
gluten-free
diet
(GFD)
is
best
treatment
for
clinical
gluten
sensitivity
(GS)
[(e.g.coeliac
disease
(CD),
nonceliac
(NCGS)],
scientific
opinion
supports
that
safe
general
population
[1].However,
celebrity/athletic
endorsement
of
GFD
has
cultivated
an
image
as
"unhealthy"
[2]."Lifestylers",
"free
from"
or
"people
who
avoid
gluten"
are
individuals
a
lifestyle
choice.American
market
research
[3]
found
44%
people
buy
food
reasons
other
than
GS,
and
65%
believe
generally
healthier.This
trend
driven
worldwide
industry
from
values
$1.7bn
2011
to
$3.5bn
2016,
it
forecast
reach
$4.7bn
2020
[4].The
surge
popularity
also
encouraged
opposing
belief
"fad"
[2].This
unfortunate
with
CD/NCGS
express
they
taken
seriously
restaurants,
even
face
dismissive
attitudes
non-specialist
clinicians
[5].The
drawing
clear
line
between
those
do
benefit
needed
ground
public
perspective
on
these
issues.For
this
reason,
conjunction
(BBC)
we
undertook
televised
experiment.Our
hypothesis
was
giving
volunteers
(via
gluten-containing
flour)
should
cause
any
symptoms.Participants
(who
received
no
financial
incentives),
recruited
by
BBC
advertising,
were
≥18
years,
had
diagnosed
gluten-related
disorders
followed
diets.The
experiment
aimed
recruit
30
subjects
divide
into
two
groups;
previous
data
available
but
NCGS
Double
Blind
Randomised
Controlled
Trials
(DBRCT)
have
reported
symptom
changes
induced
which
would
carry
89.2%
power
if
observed
within
group
N=15
[6].Participants
point
care
tested
(IgA/
BMC Gastroenterology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Sept. 17, 2024
The
impact
of
prior
SARS-CoV-2
infection
on
postoperative
recovery
patients
who
underwent
liver
resection
for
hepatocellular
carcinoma
(HCC)
remains
uncertain
given
the
lack
sufficient
evidence.
Gastrointestinal Disorders,
Journal Year:
2023,
Volume and Issue:
5(1), P. 15 - 27
Published: Jan. 5, 2023
Background:
Vaccination
against
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
recommended
for
patients
with
chronic
liver
diseases
as
the
vaccine
can
prevent
and/or
reduce
severity
of
SARS-CoV-2
infection.
However,
we
have
little
information
on
often-reported
liver-related
adverse
events
(LrAEs)
caused
by
mRNA
vaccine.
Methods:
We
retrospectively
investigated
frequency
and
details
LrAEs
changes
in
function
tests
diseases.
Results:
Among
431
diseases,
416
(96.5%)
had
received
≥
times.
345
included
analysis,
6
(1.7%)
LrAEs;
3
ascites,
increases
transaminases,
1
an
increase
total
bilirubin.
Multivariate
analysis
demonstrated
that
cirrhosis
autoimmune
disease
were
risk
factors
LrAEs.
In
contrast,
reserve
assessed
Child–Pugh
ALBI
scores
did
not
markedly
change
after
vaccination
despite
a
small
transaminase
levels.
Conclusion:
vaccines,
which
used
most
our
patients,
are
safe
but
slightly
increased
Healthcare,
Journal Year:
2023,
Volume and Issue:
11(9), P. 1207 - 1207
Published: April 23, 2023
(1)
Background:
The
COVID-19
epidemic
is
still
global
and
no
specific
drug
has
been
developed
for
COVID-19.
Vaccination
can
both
prevent
infection
limit
the
spread
of
epidemic.
Eliminating
hesitation
to
vaccine
achieving
early
herd
immunity
a
common
goal
all
countries.
However,
efforts
in
this
area
have
not
significant
there
long
way
go
eliminate
hesitancy.
(2)
Objective:
This
study
aimed
uncover
differences
characteristics
sentiments
hesitators
on
Chinese
social-media
platforms
achieve
classification
vaccine-hesitant
groups.
(3)
Methods:
COVID-19-vaccine-hesitation
posts
user
were
collected
Sina
Microblog
platform
posting
times
spanning
one
year,
identified
types.
Logistic
regression
was
used
conduct
user-group
analysis.
between
various
types
analysed
according
four
characteristics:
gender,
address
type,
degree
personal-information
disclosure,
whether
they
followed
health
topics.
Sentiment
analysis
conducted
using
sentiment
tools
calculate
scores
polarity
posts,
K-W
test
posts.
(4)
Results:
There
are
posted
by
users
with
different
characteristics,
differ
terms
sentiment.
Differences
attributes
behaviors
found
across
Ultimately,
two
COVID-19-vaccine-hesitant
groups
identified:
Body-related
Non-bodily-related.
Users
who
body-related
vaccine-hesitation
more
often
female,
disclose
personal
information
follow
topics
platforms.
non-bodily-related
male,
less
information,
do
average
score
COVID-19-vaccine-hesitant-type
than
0.45,
negative-sentiment
outweighing
positive-
neutral-sentiment
each
among
which
"Individual
rights"
type
most
negative.
(5)
Conclusions:
paper
complements
application
field
hesitation,
results
group
post
help
provide
an
in-depth
comprehensive
concerns
needs
hesitators.
will
public-health
agencies
implement
targeted
strategies
hesitancy
improve
their
work
related
vaccine,
far-reaching
implications
COVID-19-vaccine
promotion
vaccination.
Gastrointestinal Tract,
Journal Year:
2023,
Volume and Issue:
1
Published: Aug. 3, 2023
Due
to
the
COVID-19
pandemic’s
high
death
rate
and
rapid
spread,
an
effective
vaccination
is
urgently
needed.
The
detrimental
consequences
of
have
received
a
lot
attention
in
reports
on
vaccine’s
side
effects.
liver
problem
that
appears
after
getting
immunization
causes
clinical
hepatology
considerable
concern.
Hepatitis
one
issues
vaccine
may
cause.
Often,
autoimmune
pathogenic
process
mentioned
relation
pathophysiology.
Although
precise
cause
vaccine-related
dysfunction
not
yet
understood,
immunopathological
mechanisms
are
likely
be
involved.